KBP vaccine candidate poised for human trials, company says
Earlier this year, British American Tobacco announced its biotech subsidiary, Kentucky BioProcessing, was developing a potential vaccine for COVID-19. |!| Owensboro
Earlier this year, British American Tobacco announced its biotech subsidiary, Kentucky BioProcessing, was developing a potential vaccine for COVID-19. |!| Owensboro